top of page
press releases


Syndex Bio Unveils mcPCR Technology at AGBT 2026 Following $15.5M Seed Financing
mcPCR enables precise copying of DNA methylation during DNA amplification, overcoming a fundamental limitation of PCR, and unlocks new opportunities for sensitive detection of cancer, chronic disease, and in basic research Launch follows successful close of oversubscribed $15.5 million seed financing led by ARCH Venture Partners Gautam Kollu, former CCO of Grail, joins Board Syndex Bio to showcase data at AGBT in Orlando, FL from 23–26 February Cambridge, UK, 23 February 2026
Feb 23
bottom of page